Aurora Labs (ASX:A3D) Rises 10.71%: What Is Ahead for Its Defence Business?

Sonal Goyal

12 November 2026 11:29 PM AEDT

Aurora Labs (ASX:A3D) Rises 10.71%: What Is Ahead for Its Defence Business?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key highlights

Aurora Labs shares closed at 6.2 cents on 12 November 2026, up 10.71%, while the S&P/ASX 200 eased 0.07%.
Two AU4 micro gas turbine propulsion systems were sold to UK-based Tanglewood Group, valued at about A$32,000 including integration services.
The sale is for evaluation by an international defence customer, with potential production Supply in CY27.

Shares in Aurora Labs Limited (ASX:A3D) closed at 6.2 cents on 12 November 2026, up 10.71% on the session. S&P/ASX 200 closed at 9,146.80, down 0.07%. Aurora develops micro gas turbine propulsion technology. Its latest update was an announcement dated 4 November 2026 on the UK engine sale.

The UK sale

The two AU4 turbojet engines are being sold to Tanglewood Group, Aurora's strategic partner for the UK and Europe, for evaluation by an international defence customer. The company described the initial value as modest, but said it creates a direct commercial engagement with the end customer.

Pathway to larger supply

The evaluation is intended to inform future Volume requirements and production-standard propulsion systems in the 250-newton-plus thrust class, with potential supply commencing in CY27 if technical and commercial requirements are met. Tanglewood will also explore UK-based Manufacturing and supply chain partnerships. The company cited earlier US propulsion sales and a collaboration with MBDA.

Sector context

Defence spending in Europe and the UK is rising, and governments are seeking sovereign supply for propulsion. The broader index was little changed on 12 November.

Risks and limitations

The initial sale is small, and any larger program depends on the evaluation outcome, technical agreement and customer decisions that are outside Aurora's control. Timing toward CY27 is subject to those steps.

What to watch ahead

Results of the customer evaluation, any volume orders and progress on UK manufacturing partnerships will be the next signals.

FAQs

Q: What was the closing price of Aurora Labs on 12 November 2026?

A: Shares closed at 6.2 cents, up 10.71% on the session.

Q: How much was the UK sale worth?

A: About A$32,000, including engine supply and integration services.

Q: When could larger supply start?

A: Potentially in CY27, subject to evaluation and agreement.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.